Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05990790Phase 4Recruiting
Phase 4, randomised, single-blind trial of desflurane (3 arms), sponsored by Medical University of Vienna. Primary endpoint: Incidence of postoperative delirium at 5 days. Started Sep 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05990790.